HomeInsightsPE

Fermenta Biotech Ltd PE Ratio

Fermenta Biotech Ltd PE Ratio

stocks purchased

₹ 2.6 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

62.5 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Fermenta Biotech Ltd

NSE: FERMENTABIOTEC

PE

142.4

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Fermenta Biotech Ltd is 142.4 as of 11 Dec 9.00 AM .
  • The P/E Ratio of Fermenta Biotech Ltd changed from 6.4 on March 2019 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 years.
  • The Latest Trading Price of Fermenta Biotech Ltd is ₹ 410 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Fermenta Biotech Ltd

No data available

Company Fundamentals for Fermenta Biotech Ltd

No data available

Image

Fermenta Biotech Ltd

NSE: FERMENTABIOTEC

Share Price

₹ 410

-4.95 (-1.19%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Fermenta Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Fermenta Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024410
10 Dec 2024414.95
09 Dec 2024418.65
06 Dec 2024407.4
05 Dec 2024414.2
04 Dec 2024389.05
03 Dec 2024406.85
02 Dec 2024363.75
29 Nov 2024360.8
28 Nov 2024364.9

SWOT Analysis Of Fermenta Biotech Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Fermenta Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Fermenta Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Fermenta Biotech Ltd1421,206
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Fermenta Biotech Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Fermenta Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Fermenta Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Fermenta Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Fermenta Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payout of Fermenta Biotech Ltd

No data available

* All values are in %

About Fermenta Biotech Ltd

  • Promoted by a technocrat, D V K Raju, Duphar-Interfran (DIL) was incorporated in May '51 as International Franchises Pvt Ltd. In the initial years, the company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities on a loan-licence basis.
  • It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London.
  • These collaborators participated in the equity capital of the company to the extent of 25% each. The company changed its name to Crookes Interfran on 19 Apr.'63.
  • In 1964, it entered into a collaboration with Solvay Duphar to manufacture vitamin D3.
  • To associate fully with its research-oriented collaborators, in May '71, it changed its name to Duphar-Interfran.

Fermenta Biotech Ltd News Hub

News

Fermenta Biotech reports consolidated net loss of Rs 5.82 crore in the June 2024 quarter

Net loss of Fermenta Biotech reported to Rs 5.82 crore in the quarter ended June 2024 as a...

Read more

2024-08-12 00:00:00

News

Fermenta Biotech to discuss results

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 12 August...

Read more

2024-08-07 00:00:00

News

Fermenta Biotech reports consolidated net profit of Rs 11.38 crore in the September 2024 quarter

Net profit of Fermenta Biotech reported to Rs 11.38 crore in the quarter ended September 2...

Read more

2024-11-14 00:00:00

News

Fermenta Biotech to discuss results

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

2024-11-08 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Fermenta Biotech Ltd

What is the current PE Ratio of Fermenta Biotech Ltd?

The Current PE Ratio of Fermenta Biotech Ltd is 142.36 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Fermenta Biotech Ltd last year?

The PE Ratio of Fermenta Biotech Ltd was 0.0 last year, now the PE ratio is 142.36, showing a year-on-year growth of -%.

What does the PE Ratio of Fermenta Biotech Ltd indicate about its stock?

The PE Ratio of Fermenta Biotech Ltd is 142.36. This ratio indicates that investors are willing to pay 142.36 times the earnings per share for each share of Fermenta Biotech Ltd.

What is the PE Ratio Growth of Fermenta Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Fermenta Biotech Ltd grew by -% whereas, the EPS ratio grew by -296.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions